| Motto | Giving hope through collaboration |
|---|---|
| Established | 28 May 2010 |
| Director | Professor Philip Hogg |
| Faculty | UNSW Sydney |
| Adjunct faculty | Children's Cancer Institute |
| Location | Corner of Botany and High Streets, Randwick, New South Wales, Australia |
| Website | www |
The Lowy Cancer Research Centre is a facility at The University of New South Wales. It is Australia's first facility bringing together researchers in childhood and adult cancers, and one of the country's largest cancer research facilities, housing up to 400 researchers. The centre, named for businessman Frank Lowy, who donated $10 million towards the project, was officially opened on 28 May 2010. [1] It is home to researchers from the UNSW Faculty of Medicine and Children's Cancer Institute Australia. The inaugural director is Professor Philip Hogg, winner of the Cancer Institute NSW Premier's Award for Outstanding Cancer Research in 2009. [2] [3]
The Lowy Cancer Research Centre was built with funding from numerous private and government organisations, including Frank Lowy, who gifted $10 million; [1] the Australian Government, that granted $13.3 million; [4] the Australian Cancer Research Foundation (ACRF), that granted $3.1 million for the establishment of the ACRF Drug Discovery Centre for Childhood Cancer; [5] [6] and the bulk of the $127 million cost was generated from the sale of the Little Bay sporting fields at UNSW, which were sold for $103 million. [7] [8] Lahznimmo Architects, in association with Wilson Architects, designed The Lowy Cancer Research Centre with environmental sustainability in mind. [9]
The centre was officially opened on 28 May 2010 by the Prime Minister Kevin Rudd and the NSW Premier Kristina Keneally. [10] At the official opening Rudd said: [11]
"To take us further we need research. And that is where the Lowy Centre will come into its own.
— Kevin Rudd, Prime Minister of Australia, May 2010
The Lowy Cancer Symposium is a biennial cancer conference, hosted by the Lowy Cancer Research Centre in Sydney. Designed for basic research scientists, oncologists and other healthcare professionals, this cancer symposium is Australia's only Cancer Drug Discovery Symposium and focuses on the three key phases of cancer therapeutic development: discovery, pre-clinical and clinical. [12] [13]
The symposium brings together Australian and international leading cancer researchers to discuss real-time breakthroughs in cancer treatments and cures. [14]
The first Lowy Cancer Symposium with the theme Discovering Cancer Therapeutics was held on 16–18 May 2010 leading up to the official opening of the new Centre. Among the notable guests were Nobel Laureate K Barry Sharpless, Vishva Dixit, and Nicholas Dracopoli. [15]
Launch celebrations for the new ACRF Drug Discovery for Childhood Cancer, which is housed in the Lowy Cancer Research Centre, were also held during the symposium. [5]
The second Lowy Cancer Symposium was held 15–17 May 2013 at UNSW, highlighting Australasia's cancer research breakthroughs and showcasing some of the best international cancer research, including an address from Dr Lewis Cantley, director of the Cancer Center at Weill Cornell Medical College in New York. [16]
The University of New South Wales (UNSW), also known as UNSW Sydney, is a public research university based in Sydney, New South Wales, Australia. It is one of the founding members of Group of Eight, a coalition of Australian research-intensive universities. It is ranked 19th in the world in the 2024 QS World University Rankings.
The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.
WEHI, previously known as the Walter and Eliza Hall Institute of Medical Research, and as the Walter and Eliza Hall Institute, is Australia's oldest medical research institute. Sir Frank Macfarlane Burnet, who won the Nobel Prize in 1960 for his work in immunology, was director from 1944 to 1965. Burnet developed the ideas of clonal selection and acquired immune tolerance. Later, Professor Donald Metcalf discovered and characterised colony-stimulating factors. As of 2015, the institute hosted more than 750 researchers who work to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C.
Sir Frank P. Lowy is an Australian-Israeli businessman of Jewish Slovak-Hungarian origins and the former long-time chairman of Westfield Corporation, a global shopping centre company with US$29.3 billion of assets under management in the United States, United Kingdom and Europe. In June 2018 Westfield Corporation was acquired by French company Unibail-Rodamco.
The Faculty of Law and Justice of the University of New South Wales is a law school situated in Sydney, Australia. It is widely regarded as one of Australia's top law schools. The 2021 QS World University Rankings rank the UNSW Law Faculty 13th in the world, first for undergraduate law in Australia, 2nd overall in Australia and 3rd in the Asia-Pacific region, and the 2021 Times Higher Education subject rankings also rank it second in Australia, making it the top ranked law school in New South Wales according to both tables, as well as being the top undergraduate Law school in the country.
Robert John Carr is an Australian retired politician and journalist who served as the 39th Premier of New South Wales from 1995 to 2005, as the leader of the New South Wales branch of the Australian Labor Party. He later entered federal politics as a New South Wales senator, and served as Minister for Foreign Affairs from 2012 to 2013. Following his departure from politics he served as the Director of the Australia-China Relations Institute (ACRI) from 2014 to 2019 at the University of Technology Sydney (UTS).
The Victor Chang Cardiac Research Institute (VCCRI) is an Australian non-profit medical research facility that is dedicated to finding cures for cardiovascular disease. With headquarters located in Darlinghurst, New South Wales, the research hub is home to more than 20 research laboratories and the Victor Chang Cardiac Research Institute Innovation Centre. The institute's mission is "the relief of pain and suffering, and the promotion of well-being, through an understanding of the fundamental mechanisms of cardiovascular disease". Its key research is focused on the prevention and treatment of various heart diseases, including arrhythmia, cardiac arrest, cardiomyopathy, congenital heart disease, heart attack, heart failure, high cholesterol, obesity, spontaneous coronary artery dissection (SCAD) and stroke.
The Australian Cancer Research Foundation (ACRF) is an Australian not-for-profit organisation which funds research into the prevention, diagnosis and treatment of all types of cancer. It provides multimillion-dollar grants for high-end research equipment, technologies, and infrastructure development to support the work of Australian cancer scientists.
Neuroscience Research Australia is an independent, not for profit medical research institute based in Sydney, Australia.
Levon Michael Khachigian is an Australian medical research scientist notable for his work in vascular cell and molecular biology. He is a Professor in the Faculty of Medicine at the University of New South Wales.
The Heart Research Institute (HRI) is a not-for-profit research facility, originally based in Camperdown, New South Wales, Australia and currently based in Newtown, New South Wales.
Katharina Gaus was a German-Australian immunologist and molecular microscopist. She was an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab, part of the Centre for Vascular Research at the University of New South Wales. Gaus used new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells, and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.
Michelle Haber is an Australian cancer researcher in the field of childhood cancer research.
Vanessa Hayes is a geneticist conducting research into cancer genomics and comparative human genomics. She leads a research group at the Garvan Institute of Medical Research in Sydney Australia and holds the Petre Chair of Prostate Cancer Research at the University of Sydney.
Steven Mark Lowy is the former co-Chief Executive Officer of Westfield Corporation, a leading global shopping centre company that was acquired by French company Unibail-Rodamco in 2018 in what was one of the largest transactions in Australian corporate history. His principal activities now focus on investments associated with the Lowy family’s private company, Lowy Financial Group, as well as a number of philanthropic and community roles including as Chairman of the World Board of Trustees of Keren Heysod-United Israel Appeal and President of the Hakoah Club.
Ian Jacobs is an academic, medical doctor, gynaecological oncologist, charity founder and university leader from the UK, with dual British and Australian citizenship.
Children's Cancer Institute is an Australian medical research institute wholly dedicated to the prevention and treatment of childhood cancer. Established in 1976, the Institute is affililiated with both the University of New South Wales and Sydney Children's Hospital and is located in Randwick, Sydney, New South Wales.
Ren Michael Pedersen is an advocate for children's brain cancer research.
Maria Kavallaris is an Australian scientist, based at the University of New South Wales' Children's Cancer Institute, where she is best known for her contributions to the field of cancer research. On 25 January 2019, Kavallaris was appointed a member of the Order of Australia.
Eileen Baldry is an Australian criminologist and social justice advocate. She is Deputy Vice-Chancellor Equity Diversity and Inclusion and Professor of Criminology at the University of New South Wales (UNSW).
{{cite web}}: CS1 maint: archived copy as title (link)